"赣江新区有完整生态，有脑机接口的专项扶持，一对一服务的专员。这是我们选择将'主战场'放到这 儿的原因。"翔宇健康集团副总裁李运华说，期待该区继续发挥创新合伙人的角色，缩短企业创新周 期，让前沿技术能尽早普及到百姓身边。 下一步，赣江新区还将推出《关于加快打造脑机接口未来产业先导区的行动方案》，奋力推动未来产业 发展、打造新的经济增长点。 （文章来源：科技日报） 12月29日，江西赣江新区脑机接口产业项目迎来集中签约仪式活动。该活动集中签约15个优质项目，覆 盖产业链上中下游与各类技术路线。 赣江新区管委会主任王万征表示，该区全力推动脑机接口产业从"单点突破"向"生态集聚"发展，主动出 击、精准招引产业链上下游企业，积极推动聚链成群，为抢先布局未来产业赛道、打造新的经济增长点 提供强劲助力；针对脑机接口企业在临床资源、检测取证、应用场景等方面的需求，协力打造"五大支 撑体系"。 此次集中签约的项目覆盖了脑机接口产业上游的MEMS芯片、高精度电极，中游的cro服务平台、数据 处理以及下游针对睡眠、康复等应用场景的机器人、神经调控设备等关键环节，将在赣江新区形成覆 盖"研发—生产—临床—应用"的脑机接口全产业链。 ...

转自：南昌发布 此次集中签约的项目覆盖了脑机接口产业上游的MEMS芯片、高精度电极，中游的cro服务平台、数据处理以及下游针对睡眠、康复等应用场景的机器 人、神经调控设备等关键环节，将在赣江新区形成覆盖"研发—生产—临床—应用"的脑机接口全产业链。为推动脑机接口产业发展，赣江新区针对临床资 源需求，建立"1+1+3"临床对接机制；针对检测取证需求，建设省级脑机接口产品检测中心；针对应用场景需求，丰富康复医疗场景；针对资本人才需 求，完善政策基金支持体系；针对算力数据需求，打造公共数据服务平台。下一步，赣江新区还将推出《关于加快打造脑机接口未来产业先导区的行动方 案》，奋力推动未来产业发展、打造新的经济增长点。 来源：洪观新闻记者 万能/文 成奔/图 编辑：梁琼 二审：胡志文 终审：凌云 12月29日，赣江新区脑机接口产业项目集中签约活动举行。省委常委、南昌市委书记、赣江新区党工委书记李红军出席并见证签约。赣江新区管委会主任 王万征介绍产业发展情况。赣江新区党工委专职副书记罗进主持。省科技厅、省工信厅、省卫生健康委、省市场监管局、省国有资本运营控股集团负责同 志以及部分医院、企业代表，赣江新区党工委委员、管委会 ...

Core Insights - Medtronic has appointed Dr. Joon Lee as a new independent board member, effective June 18, 2025, bringing valuable insights from his experience in healthcare management and innovation [1][7]. Company Overview - Medtronic, founded in 1949 and headquartered in Minneapolis, Minnesota, is a leading global medical technology company with over 95,000 employees [8]. - The company focuses on providing lifelong treatment solutions for chronic disease patients, impacting two patients every second globally with its medical technologies [8]. Dr. Joon Lee's Background - Dr. Lee is currently the CEO of Emory Healthcare, Georgia's largest academic medical system, with an annual revenue of approximately $5.6 billion [4]. - He has extensive experience in healthcare policy, hospital operations, and patient-provider relationships, having served in various leadership roles for over 25 years at UPMC [5][6]. - Dr. Lee has a strong focus on digital transformation in healthcare and has successfully enhanced public health response capabilities during the COVID-19 pandemic [6]. Significance of Dr. Lee's Appointment - Dr. Lee's perspective as a healthcare service provider will help Medtronic better understand hospital purchasing decisions, clinical needs, and patient experiences [7]. - His expertise is expected to drive the adoption of Medtronic's products, particularly in cardiovascular and neuroscience sectors [7]. Recent Developments - Medtronic announced plans to spin off its diabetes business, including the MiniMed insulin pump, into a standalone public company by November 2026 [12]. - The company is investing in the Hugo robotic-assisted surgery system and pulse field ablation technology for atrial fibrillation treatment [12]. - Medtronic is expanding globally, with a $50 million investment to establish a diabetes Global Capability Center in Pune, India, creating 600 jobs [12].